Original language | English |
---|---|
Pages (from-to) | 159-163 |
Number of pages | 5 |
Journal | Journal of Infection and Chemotherapy |
Volume | 24 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2018 Mar |
Keywords
- C-reactive protein
- Community-acquired pneumonia
- Diagnostic predictors
- Legionella
- Serum sodium
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
- Pharmacology (medical)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Diagnostic predictors of Legionella pneumonia in Japan. / Miyashita, Naoyuki; Horita, Nobuyuki; Higa, Futoshi; Aoki, Yosuke; Kikuchi, Toshiaki; Seki, Masafumi; Tateda, Kazuhiro; Maki, Nobuko; Uchino, Kazuhiro; Ogasawara, Kazuhiko; Kiyota, Hiroshi; Watanabe, Akira.
In: Journal of Infection and Chemotherapy, Vol. 24, No. 3, 03.2018, p. 159-163.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Diagnostic predictors of Legionella pneumonia in Japan
AU - Miyashita, Naoyuki
AU - Horita, Nobuyuki
AU - Higa, Futoshi
AU - Aoki, Yosuke
AU - Kikuchi, Toshiaki
AU - Seki, Masafumi
AU - Tateda, Kazuhiro
AU - Maki, Nobuko
AU - Uchino, Kazuhiro
AU - Ogasawara, Kazuhiko
AU - Kiyota, Hiroshi
AU - Watanabe, Akira
N1 - Funding Information: Akira Watanabe has received speaker honoraria from MSD K.K., Kobayashi Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Mitsubishi Tanabe Pharma Co., Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc., UCB Japan Co. Ltd., AbbVie GK, and GlaxoSmithKline K.K.; donations from Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., and Sumitomo Dainippon Pharma Co., Ltd.; payments for manuscript drafting and editing from Iyaku (Medicine and Drug) Journal Co., Ltd.; and grant support from Kyorin Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd., Fujifilm Pharma Co., Ltd., and Meiji Seika Pharma Co., Ltd. Funding Information: Toshiaki Kikuchi has received grant support from Chugai Pharmaceutical Co., Ltd., Boehringer Ingelheim Japan, Inc., Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., and Astellas Pharma Inc. Funding Information: Yosuke Aoki has received speaker honoraria from MSD K.K., Shionogi & Co., Ltd., and Taisho Toyama Pharmaceutical Co., Ltd.; and grant support from Shionogi & Co., Ltd. Funding Information: Kazuhiro Tateda has received speaker honoraria from Pfizer Japan Inc., MSD K.K., Sumitomo Dainippon Pharma Co., Ltd., Meiji Seika Pharma Co., Ltd., and Taisho Toyama Pharmaceutical Co., Ltd.; research funding from Otsuka Pharmaceutical Co., Ltd., grant support from Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., Pfizer Japan Inc., Taiho Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Japan Blood Products Organization, Asahi Kasei Pharma Corporation, Sumitomo Dainippon Pharma Co., Ltd., Shionogi & Co., Ltd., Meiji Seika Pharma Co., Ltd., and Toyama Pharmaceutical Co., Ltd.; and donations from Kyorin Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., Astellas Pharma Inc., Meiji Seika Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., and MSD K.K.
PY - 2018/3
Y1 - 2018/3
KW - C-reactive protein
KW - Community-acquired pneumonia
KW - Diagnostic predictors
KW - Legionella
KW - Serum sodium
UR - http://www.scopus.com/inward/record.url?scp=85041524239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041524239&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2017.12.009
DO - 10.1016/j.jiac.2017.12.009
M3 - Article
AN - SCOPUS:85041524239
VL - 24
SP - 159
EP - 163
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
SN - 1341-321X
IS - 3
ER -